|
|
News Breaks
|
October 27, 2009
|
| 11:22 EDT |  | OREX |
| theflyonthewall.com: | Orexigen releases new efficacy data for Contrave | | Orexigen Therapeutics announced results from new intent to treat analyses from the COR-I and COR-II Phase 3 trials of Contrave, the first of two late stage Orexigen candidates for the treatment of obesity. These data expand on top-line results announced in July and complement findings from a panel discussion on Saturday where the Company presented data on Contrave patients who completed 56 weeks of therapy. These ITT data were presented today in two late breaker oral presentations at the 27th Annual Scientific Meeting of The Obesity Society in Washington, D.C. :theflyonthewall.com |
|
|
News For OREX From The Last 14 Days Check below for free stories on OREX the last two weeks.
There is 1 item on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 6, 2012
|
| 08:12 EDT | | OREX |
|
|
|
|
|
Subscribe for More Information